Latest news
-
10 October 2018 -
16 April 2018 Almac Diagnostic Services Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials
Read more
-
12 February 2018 Almac Diagnostic Services Partners with DNAnexus to Power Clinical Trial Assay Development
Read more
-
23 October 2017 Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment
Read more
-
13 June 2017 Almac Group Awarded U.S. Patents for Ground-breaking “DDRD” Assay
Read more
-
20 April 2017 Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
Read more
-
08 March 2017 Almac Diagnostic Services and EORTC Establish Collaboration for Tumor Molecular Profiling
Read more
-
16 February 2017 Almac Diagnostic Services Appoints Dr Leeona Galligan as Vice President UK Operations
Read more
-
10 October 2016 Almac Group Discover an Exciting Link between its Immune Response Assay and Checkpoint Inhibitor Based Therapy
Read more